Federal Register Notice: FDA’s Vaccines and Related Biological Products Advisory Committee will meet 2/27, from 8 a.m. to 5:30 p.m. and on 2/28, from 8 a.m. to 4:15 p.m. at the Hilton Hotel, Washington DC North/Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD 20877. On 2/27, in the morning session, the committee will hear presentations and make recommendations on the safety and effectiveness of Sanofi Pasteur’s H5N1 inactivated influenza vaccine. In the afternoon, the committee will hear presentations and have discussions on clinical development of influenza vaccines for pre-pandemic uses. On 2/28, in the morning, the committee will hear presentations and make recommendations on strain selections for the influenza virus vaccine for the 2007-2008 season. In the afternoon, the committee will hear presentations and have discussions on circulating lineages of influenza type B virus. Contact Christine Walsh or Denise Royster (301) 827-0314. To view this notice, click here.